Joshua Makower - Net Worth and Insider Trading

Joshua Makower Net Worth

The estimated net worth of Joshua Makower is at least $331 Million dollars as of 2024-04-26. Joshua Makower is the 10% Owner of Mirum Pharmaceuticals Inc and owns about 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) stock worth over $104 Million. Joshua Makower is the 10% Owner of AVEO Pharmaceuticals Inc and owns about 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) stock worth over $59 Million. Joshua Makower is also the 10% Owner of Akouos Inc and owns about 4,294,207 shares of Akouos Inc (AKUS) stock worth over $57 Million. Besides these, Joshua Makower also holds Monte Rosa Therapeutics Inc (GLUE) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Achaogen Inc (AKAOQ) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , ARCA biopharma Inc (ABIO) . Details can be seen in Joshua Makower's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua Makower has not made any transactions after 2021-06-28 and currently still holds the listed stock(s).

Transaction Summary of Joshua Makower

To

Joshua Makower Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Joshua Makower owns 31 companies in total, including Eargo Inc (EAR) , Metacrine Inc (MTCR) , and Inozyme Pharma Inc (INZY) among others .

Click here to see the complete history of Joshua Makower’s form 4 insider trades.

Insider Ownership Summary of Joshua Makower

Ticker Comapny Transaction Date Type of Owner
EAR Eargo Inc 2020-10-20 director & 10 percent owner
MTCR Metacrine Inc 2020-09-18 10 percent owner
INZY Inozyme Pharma Inc 2020-07-28 10 percent owner
GNCAQ Genocea Biosciences Inc 2020-07-24 10 percent owner
ANNX Annexon Inc 2020-07-23 10 percent owner
NKTX Nkarta Inc 2020-07-09 10 percent owner
AKUS Akouos Inc 2020-06-30 10 percent owner
AVEO AVEO Pharmaceuticals Inc 2020-06-19 10 percent owner
TRVI Trevi Therapeutics Inc 2020-04-03 10 percent owner
BDTX Black Diamond Therapeutics Inc 2020-01-29 10 percent owner
RGLS Regulus Therapeutics Inc 2020-12-04 10 percent owner
ARDX Ardelyx Inc 2016-07-18 10 percent owner
MIRM Mirum Pharmaceuticals Inc 2019-07-22 10 percent owner
NITE Nightstar Therapeutics PLC 2019-06-07 10 percent owner
MLND Millendo Therapeutics Inc 2018-12-07 10 percent owner
MRKR Marker Therapeutics Inc 2021-03-16 10 percent owner
CASC Cascadian Therapeutics Inc 2018-03-09 10 percent owner
ABIO ARCA biopharma Inc 2018-02-26 10 percent owner
AKAOQ Achaogen Inc 2016-12-19 10 percent owner
IRIX IRIDEX Corp 2003-07-01 director
SVRA Savara Inc 2021-03-15 10 percent owner
TPST Tempest Therapeutics Inc 2018-12-07 10 percent owner
RPHM Reneo Pharmaceuticals Inc 2021-04-08 10 percent owner
VRNA Verona Pharma PLC 2021-01-01 10 percent owner
NEUE NeueHealth Inc 2021-06-24 10 percent owner
DM Desktop Metal Inc 2020-12-09 10 percent owner
HOOD Robinhood Markets Inc 2021-07-29 director & 10 percent owner
BGRY Berkshire Grey Inc 2021-07-21 10 percent owner
GLUE Monte Rosa Therapeutics Inc 2021-06-28 10 percent owner
GGNNQ Genocea Biosciences Inc 2018-01-19 10 percent owner
RAACU Revolution Acceleration Acquisition Corp 2021-07-21 10 percent owner

Joshua Makower Latest Holdings Summary

Joshua Makower currently owns a total of 14 stocks. Among these stocks, Joshua Makower owns 4,186,243 shares of Mirum Pharmaceuticals Inc (MIRM) as of July 22, 2019, with a value of $104 Million and a weighting of 31.36%. Joshua Makower owns 3,952,958 shares of AVEO Pharmaceuticals Inc (AVEO) as of June 19, 2020, with a value of $59 Million and a weighting of 17.94%. Joshua Makower also owns 4,294,207 shares of Akouos Inc (AKUS) as of June 30, 2020, with a value of $57 Million and a weighting of 17.26%. The other 11 stocks Monte Rosa Therapeutics Inc (GLUE) , Ardelyx Inc (ARDX) , Trevi Therapeutics Inc (TRVI) , Inozyme Pharma Inc (INZY) , Marker Therapeutics Inc (MRKR) , Regulus Therapeutics Inc (RGLS) , Eargo Inc (EAR) , Achaogen Inc (AKAOQ) , Metacrine Inc (MTCR) , Genocea Biosciences Inc (GNCAQ) , ARCA biopharma Inc (ABIO) have a combined weighting of 33.44% among all his current holdings.

Latest Holdings of Joshua Makower

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
MIRM Mirum Pharmaceuticals Inc 2019-07-22 4,186,243 24.77 103,673,145
AVEO AVEO Pharmaceuticals Inc 2020-06-19 3,952,958 15.00 59,294,370
AKUS Akouos Inc 2020-06-30 4,294,207 13.29 57,070,011
GLUE Monte Rosa Therapeutics Inc 2021-06-28 7,692,298 5.41 41,615,332
ARDX Ardelyx Inc 2016-07-18 5,331,039 6.51 34,678,409
TRVI Trevi Therapeutics Inc 2020-04-03 5,937,998 2.74 16,270,708
INZY Inozyme Pharma Inc 2020-07-28 2,437,689 4.41 10,738,020
MRKR Marker Therapeutics Inc 2021-03-16 1,071,429 4.40 4,714,288
RGLS Regulus Therapeutics Inc 2020-12-04 645,106 2.43 1,564,382
EAR Eargo Inc 2020-10-20 326,001 2.57 837,823
AKAOQ Achaogen Inc 2016-12-19 5,215,128 0.03 130,378
MTCR Metacrine Inc 2020-09-18 3,060,527 0.00 4,285
GNCAQ Genocea Biosciences Inc 2020-07-24 10,376,936 0.00 1,038
ABIO ARCA biopharma Inc 2018-02-26 0 3.59 0

Holding Weightings of Joshua Makower


Joshua Makower Form 4 Trading Tracker

According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in Mirum Pharmaceuticals Inc (MIRM) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Mirum Pharmaceuticals Inc is the acquisition of 450,000 shares on July 22, 2019, which cost Joshua Makower around $7 Million.

According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in AVEO Pharmaceuticals Inc (AVEO) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in AVEO Pharmaceuticals Inc is the acquisition of 1,428,571 shares on June 19, 2020, which cost Joshua Makower around $8 Million.

According to the SEC Form 4 filings, Joshua Makower has made a total of 1 transactions in Akouos Inc (AKUS) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Akouos Inc is the acquisition of 588,235 shares on June 30, 2020, which cost Joshua Makower around $10 Million.

More details on Joshua Makower's insider transactions can be found in the Insider Trading History of Joshua Makower table.

Insider Trading History of Joshua Makower

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Joshua Makower Trading Performance

GuruFocus tracks the stock performance after each of Joshua Makower's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua Makower is 4.83%. GuruFocus also compares Joshua Makower's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua Makower within 3 months outperforms 15 times out of 32 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Joshua Makower's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Joshua Makower

Average Return

-34.21%

Average return per transaction

Outperforming Transactions

13%

4 out of 32 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 6.27 4.83 0.68 -34.21 -42.41 -39.52
Relative Return to S&P 500(%) 4.9 0.31 -7.89 -49.49 -54.16 -53.77

Joshua Makower Ownership Network

Ownership Network List of Joshua Makower

No Data

Ownership Network Relation of Joshua Makower


Joshua Makower Owned Company Details

What does Eargo Inc do?

Who are the key executives at Eargo Inc?

Joshua Makower is the director & 10 percent owner of Eargo Inc. Other key executives at Eargo Inc include Chief Accounting Officer Mark Thorpe , Chief Operating Officer William Brownie , and Chief Financial Officer Adam Laponis .

Eargo Inc (EAR) Insider Trades Summary

Over the past 18 months, Joshua Makower made no insider transaction in Eargo Inc (EAR). Other recent insider transactions involving Eargo Inc (EAR) include a net sale of 2,012 shares made by William Brownie , a net sale of 725 shares made by Adam Laponis , and a net sale of 92 shares made by Mark Thorpe .

In summary, during the past 3 months, insiders sold 0 shares of Eargo Inc (EAR) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,799 shares of Eargo Inc (EAR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,799 shares.

Eargo Inc (EAR)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Eargo Inc Insider Transactions

No Available Data

Joshua Makower Mailing Address

Above is the net worth, insider trading, and ownership report for Joshua Makower. You might contact Joshua Makower via mailing address: 1212 Terra Bella Avenue, Mountain View Ca 94043.

Discussions on Joshua Makower

No discussions yet.